Skip to main content
OpenTrials

Clinical trial condition

Urothelial Carcinoma

Explore clinical trials studying Urothelial Carcinoma. Study availability and eligibility vary by location and protocol.

239 public trials 74 recruiting studies
Refine in advanced search Browse all conditions

Urothelial Carcinoma trial results

Completed

Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

NCT05945108

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +16 more
Locations
  • Research Site Belo Horizonte, Brazil
  • Research Site Porto Alegre, Brazil
  • Research Site Recife, Brazil
  • Research Site Salvador, Brazil
View Trial Details
Completed

Phase 1b/2 Study of Rogaratinib (BAY1163877) in Combination With Atezolizumab in Urothelial Carcinoma

NCT03473756

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • University of Arizona Cancer Center Tucson, Arizona, United States
  • UChicago Medicine Comprehensive Cancer Center - Hyde Park Chicago, Illinois, United States
  • Barbara Ann Karmanos Cancer Institute - Detroit Headquarters Detroit, Michigan, United States
  • Memorial Sloan-Kettering Cancer Center New York, United States
View all 30 locations
View Trial Details
Completed

SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or Lymphomas

NCT03894618

Conditions
Adenocarcinoma, Anus Diseases, Anus Neoplasms, +68 more
Locations
  • The Sarah Cannon Research Institute Nashville, Tennessee, United States
  • The University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • Leuven Cancer Institute Leuven, Belgium
  • Princess Margaret Cancer Center Toronto, Ontario, Canada
View Trial Details
Completed

A Study to Learn About the Study Medicine (Avelumab) in Japanese Patients With Urothelial Carcinoma That Has Spread

NCT05431777

Conditions
Carcinoma, Carcinoma, Transitional Cell, Neoplasms, +3 more
Locations
  • National Hospital Organization Nagoya Medical Center Nagoya, Aichi-ken, Japan
  • Asahi General Hospital Asahi, Chiba, Japan
  • Kurume University Hospital Kurume, Fukuoka, Japan
  • Ogaki Municipal Hospital Ōgaki, Gifu, Japan
View all 16 locations
View Trial Details
Completed

Neoadjuvant Pembrolizumab in Combination With Gemcitabine Therapy in Cis-eligible/Ineligible UC Subjects

NCT02365766

Conditions
Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +14 more
Locations
  • Indiana University Melvin and Bren Simon Cancer Center Indianapolis, Indiana, United States
  • IU Health Central Indiana Cancer Center Indianapolis, Indiana, United States
  • Community Regional Cancer Care Indianapolis, Indiana, United States
  • St. Vincent Hospital Indianapolis, Indiana, United States
View Trial Details
Completed

Study of Atezolizumab as Monotherapy and in Combination With Platinum-Based Chemotherapy in Participants With Untreated Locally Advanced or Metastatic Urothelial Carcinoma

NCT02807636

Conditions
Carcinoma, Carcinoma, Transitional Cell, Female Urogenital Diseases, +13 more
Locations
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Coastal Integrative Cancer Care San Luis Obispo, California, United States
  • Yale School of Medicine New Haven, Connecticut, United States
  • Norwalk Hospital Norwalk, Connecticut, United States
View all 204 locations
View Trial Details

Related conditions